BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38110000)

  • 1. High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis.
    Tseng PT; Zeng BY; Chen JJ; Kuo CH; Zeng BS; Kuo JS; Cheng YS; Sun CK; Wu YC; Tu YK; Stubbs B; Carvalho AF; Liang CS; Chen TY; Hsu CW; Suen MW; Yang CP; Hsu SP; Chen YW; Shiue YL; Hung CM; Su KP; Lin PY
    Adv Nutr; 2024 Feb; 15(2):100163. PubMed ID: 38110000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between melatonin and episodic migraine: A pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy.
    Tseng PT; Yang CP; Su KP; Chen TY; Wu YC; Tu YK; Lin PY; Stubbs B; Carvalho AF; Matsuoka YJ; Li DJ; Liang CS; Hsu CW; Chen YW; Shiue YL
    J Pineal Res; 2020 Sep; 69(2):e12663. PubMed ID: 32347977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy.
    Tseng PT; Zeng BS; Suen MW; Wu YC; Correll CU; Zeng BY; Kuo JS; Chen YW; Chen TY; Tu YK; Lin PY; Carvalho AF; Stubbs B; Li DJ; Liang CS; Hsu CW; Sun CK; Cheng YS; Yeh PY; Wu MK; Shiue YL; Su KP
    Brain Behav Immun; 2023 Jul; 111():352-364. PubMed ID: 37150266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Yokoyama Y; Kuno T; Morita SX; Slipczuk L; Takagi H; Briasoulis A; Latib A; Bangalore S; Heffron SP
    J Cardiol; 2022 Nov; 80(5):416-422. PubMed ID: 35914996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network Meta-analysis of Different Treatments for Vestibular Migraine.
    Chen JJ; Zeng BS; Su KP; Wu YC; Tu YK; Stubbs B; Chen TY; Zeng BY; Chen YW; Hsu CW; Tseng PT
    CNS Drugs; 2023 Sep; 37(9):837-847. PubMed ID: 37676473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
    Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
    Kelaiditis CF; Gibson EL; Dyall SC
    Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
    Newberry SJ; Chung M; Booth M; Maglione MA; Tang AM; O'Hanlon CE; Wang DD; Okunogbe A; Huang C; Motala A; Trimmer M; Dudley W; Shanman R; Coker TR; Shekelle PG
    Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, Safety, and Acceptability of Pharmacologic Treatments for Pediatric Migraine Prophylaxis: A Systematic Review and Network Meta-analysis.
    Locher C; Kossowsky J; Koechlin H; Lam TL; Barthel J; Berde CB; Gaab J; Schwarzer G; Linde K; Meissner K
    JAMA Pediatr; 2020 Apr; 174(4):341-349. PubMed ID: 32040139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sixteen-week three-armed, randomized, controlled trial investigating clinical and biochemical effects of targeted alterations in dietary linoleic acid and n-3 EPA+DHA in adults with episodic migraine: Study protocol.
    Mann JD; Faurot KR; MacIntosh B; Palsson OS; Suchindran CM; Gaylord SA; Lynch C; Johnston A; Maiden K; Barrow DA; Hibbeln JR; Ramsden CE
    Prostaglandins Leukot Essent Fatty Acids; 2018 Jan; 128():41-52. PubMed ID: 29413360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
    Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
    PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials.
    Huang L; Zhang F; Xu P; Zhou Y; Liu Y; Zhang H; Tan X; Ge X; Xu Y; Guo M; Long Y
    Adv Nutr; 2023 Jul; 14(4):629-636. PubMed ID: 37121469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: A network meta-analysis of randomized controlled trials.
    Yang B; Tseng PT; Hu X; Zeng BY; Chang JP; Liu Y; Chu WJ; Zhang SS; Zhou ZL; Chu CS; Chang CH; Tu YK; Wu YC; Stubbs B; Carvalho AF; Lin PY; Matsuoka YJ; Suen MW; Su KP
    Prog Lipid Res; 2022 Nov; 88():101196. PubMed ID: 36341839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. n-3 fatty acids and cardiovascular events after myocardial infarction.
    Kromhout D; Giltay EJ; Geleijnse JM;
    N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.